99% Savings - Buy Just @1 Rs X
Septigard An, a prescription drug, is manufactured in various forms such as Cream. Other than this, Septigard An has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Septigard An. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Septigard An include Constipation. While these are the most often observed Septigard An side effects, there are can be others also. These have been listed below. Such side effects of Septigard An normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Septigard An is Moderate for pregnant women and Moderate for women who are breastfeeding. Warnings related to Septigard An's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Drug Allergy, Diabetes, Peripheral Neuropathy must refrain from the use of Septigard An since this can cause severe adverse effects. Some other conditions that can be affected by Septigard An are listed in the contraindications section below.
Drug interactions for Septigard An have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Septigard An, it is important to know that it is not safe while driving, and is not habit-forming.
Septigard An is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Septigard An safe for pregnant women?
Pregnant women may experience moderate side effects from Septigard An. It is best to stop taking Septigard An immediately and inform your doctor if you notice any discomfort.
Is the use of Septigard An safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Septigard An. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Septigard An on the Kidneys?
Septigard An rarely affects the kidneys.
What is the effect of Septigard An on the Liver?
Side effects of Septigard An rarely affect the liver.
What is the effect of Septigard An on the Heart?
There are no any side effects of Septigard An for the heart.
Septigard An should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Septigard An unless your doctor advises you to do so -
Is this Septigard An habit forming or addictive?
No, you will not get addicted to Septigard An.
Interaction between Food and Septigard An
Taking Septigard An with food is safe.
Interaction between Alcohol and Septigard An
Consult your doctor before consuming alcohol while taking Septigard An as it can have severe side effects.
Yes, Septigard An kills bacteria. It exerts its bactericidal effect by invading the cell wall of the bacteria and killing its DNA and denaturing the enzymes.
No, Septigard An should not be used for the treatment of vaginitis in pregnant women. This is because exposure to iodine-containing solution could lead to the development of hypothyroidism and goiter in the infant. Vaginitis is the swelling of the vulva or vagina. It may develop from the use of soap, perfumes, not washing well, menopause, wearing tight undergarments, etc. It can stem from a bacterial, yeast, fungal or a protozoan infection. It can be effectively managed by washing the infected area with only water, keeping it dry, taking a warm bath, wearing comfortable undergarments, keeping the blood sugar levels under control and using pads and not tampons. It is also important to use an antiseptic as per the recommendations of a doctor.
Yes, Septigard An is used for open wounds since last few decades. It remains a favorite agent for use as an antiseptic and as a wound-healing agent because of its safety, tolerability, and efficacy. Septigard An has a broad spectrum of activity, has reduced cell toxicity, low incidence of resistance has anti-inflammatory property, and is able to penetrate biofilms (cluster of microorganisms attached to the cell surface).
Yes, there have been reports of Septigard An causing acute kidney injury. Septigard An is widely used as an antiseptic and as a preoperative and postoperative surgical scrub. Its main moiety is iodine which is effective against yeast, fungi, bacteria, and protozoans. However, it is also known to cause toxicity, resulting in acute kidney injury in a person who ingested it, in people in whom it has been used topically, etc.
Yes, Septigard An is suitable for a fungal infection. Fungal infections can be managed by using a topical treatment and adhering to it, by washing the skin with slightly warm water and an antifungal soap or a wash, by keeping the skin dry, by daily washing the towel, bedsheet and the clothes, by not wearing tight clothes, etc.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tindamax® (tinidazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 839